Sign in
Stories
Rite Aid Completes Elixir Sale
Share
Drugstore Closures Raise Concerns for Vu...
Drugstore Closures and Challenges in the...
Healthcare Supply Chain Resilience
Rising Bankruptcy Trends Reshape Strateg...
Rite Aid Approves Sale of Elixir Solutio...
Rite Aid Closes Stores Amid Bankruptcy
Overview
API
Rite Aid completes the sale of Elixir, its pharmacy benefit management (PBM) company, to MedImpact for $575 million. This divestiture marks a significant milestone in Rite Aid's transformation, positioning it for long-term success in healthcare products, services, and solutions. The sale is part of Rite Aid's efforts to restructure and focus on healthcare, potentially leading to the closure of more retail locations.
Ask a question
How might Rite Aid's divestiture of Elixir impact the competitive landscape of the pharmacy benefit management industry?
How might the acquisition of Elixir by MedImpact influence the healthcare industry's focus on prescription discount programs and mail and specialty pharmacies?
What strategies could Rite Aid employ to ensure its long-term success in the healthcare sector despite potential retail location closures?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Feb 2024
Coverage